Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 320.00
Ask: 379.00
Change: 0.00 (0.00%)
Spread: 59.00 (18.438%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 358.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jul 2017 07:00

RNS Number : 4418L
City of London Investment Group PLC
19 July 2017
 

 

City of London Investment Group PLC

19 July 2017

 

This announcement contains inside information



CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Group")

 

TRADING UPDATE

for the year to 30 June 2017

 

City of London (LSE: CLIG), a leading emerging markets asset management group, provides a trading update for it's financial year ended 30 June 2017. The numbers that follow are all unaudited.

 

Funds under management were US$4.7 billion (£3.6 billion) at 30 June 2017 (2016: US$4.0 billion or £3.0 billion), representing a 17% increase in US$ terms for the year. Over the same period, the MSCI Emerging Markets TR Net Index rose by 24% in US$ terms. Net asset flows for the year in Emerging Markets were negative c US$306 million (as clients rebalanced into the significant EM equity gains) while they were positive (c US$26 million) in the Diversification strategies. Net mandate wins of c US$125 million are confirmed for early in the new financial year.

 

Investment performance vs benchmarks for all asset classes was positive with the exception of Frontier which was marginally negative.

 

The Group's overhead for the year to 30 June 2017 is expected to be £11.9 million (2016: £10.7 million) and the current monthly run-rate is c £1.0m. A significant part of this increase is as a result of the fall in GBP vs US$.

 

For the year to 30 June 2017, the Group expects that pre-tax profits will be approximately £11.6 million (2016: £8.0 million), and that profits after an anticipated tax charge of £2.5 million (22% of pre-tax profits) will be approximately £9.1 million (2016: profits of £5.9 million after a tax charge of £2.1 million, representing 27% of pre-tax profit). The tax charge includes an estimated refund of £0.4 million relating to prior years' US state taxes, which if excluded would result in a Group tax rate of 25% of pre-tax profits. Basic and fully diluted earnings per share are expected to be 36.9p and 36.7p respectively (2016: 23.3p and 23.1p).

 

The Board is recommending an increased final dividend of 17p per share (2016: 16p). This would bring the total for the year to 25p (2016: 24p), for dividend cover of 1.46 times (2016: 0.96 times).

 

The Board confirms the final dividend timetable for the year to 30 June 2017:

 

· ex-dividend date: 12 October 2017

· dividend record date: 13 October 2017

· payable: 31 October 2017

 

City of London expects to announce final results alongside publication of its Accounts for the year to 30 June 2017 on 18 September 2017. The Group's Annual General Meeting will be held on 23 October 2017.

 

Please see the attached graph which is based on the following assumptions and includes the estimated cost of a maintained dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/4418L_-2017-7-18.pdf 

 

Assumptions:

§ Starting point Current FuM (end June 2017)

§ Net increase in FuM in 2017/2018 (straight-lined to June 2018):

· emerging market strategies $250m

· diversification strategies $250m

§ Operating margin adjusted monthly for change in product mix and commission run-off

§ Market growth: 0%

§ Increase in overheads: 3%

§ EIP charge: 2%

§ Corporation tax based on an estimated average rate of 23%

§ Exchange rate assumed to be £1/$1.30 for entire period

§ Number of CLIG Shares in issue (26.9m) less those held by the Employee Benefit Trust (1.5m) as at 30 June 2017

 

This can also be found on our website at: http://www.citlon.co.uk/shareholders/announcements.php

 

CLIG shares

 

In line with his previously announced intention, during the financial year Barry Olliff sold 500,000 CLIG shares at 400p. Going forward, his revised intention is to reduce his holding progressively at 25p price increments, commencing with up to 250,000 shares at 425p and up to a further 250,000 shares at 450p. His current shareholding is 2,275,186, 8.46% of shares in issue.

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Barry Olliff, CEO

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Martin R Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

 

This release includes forward-looking statements, which may differ from actual results. Any forward-looking statements are based on certain factors and assumptions, which may prove incorrect, and are subject to risks, uncertainties and assumptions relating to future events, the Group's operations, results of operations, growth strategy and liquidity.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFMEDAFWSELW
Date   Source Headline
20th Feb 20094:09 pmRNSDividend reinvestment plan
11th Feb 20094:55 pmRNSHolding(s) in Company
9th Feb 200911:03 amRNSDirector/PDMR Shareholding
4th Feb 20093:16 pmRNSDirector/PDMR Shareholding
4th Feb 200912:04 pmRNSHolding(s) in Company
30th Jan 20099:32 amRNSTotal Voting Rights
28th Jan 20094:02 pmRNSDirector/PDMR Shareholding & TVR
28th Jan 20097:00 amRNSHalf Yearly Report
21st Jan 200912:16 pmRNSHolding(s) in Company
13th Jan 20099:00 amRNSBlock Admission & TVR
8th Dec 20087:34 amRNSFunds under Management - Replacement
8th Dec 20087:00 amRNSFunds Under Management
27th Nov 20084:31 pmRNSDirector/PDMR Shareholding
7th Nov 20089:09 amRNSDirector/PDMR Shareholding
3rd Nov 20087:00 amRNSChange of Registered Office
28th Oct 20087:00 amRNSResult of AGM
27th Oct 20087:00 amRNSAGM Trading Update
8th Oct 200810:01 amRNSChange of Adviser Name
30th Sep 200812:18 pmRNSDirector/PDMR Shareholding
30th Sep 200810:04 amRNSDirector/PDMR Shareholding
22nd Sep 20081:04 pmRNSNotifiable Interest
15th Sep 20087:00 amRNSFinal Results
14th Jul 20086:03 pmRNSDirector/PDMR Shareholding
10th Jun 20087:00 amRNSDirector/PDMR Shareholding
9th Jun 20087:00 amRNSTrading Update
19th May 20082:34 pmRNSDirectorate Change
28th Apr 20083:50 pmRNSNotifiable Interest
23rd Apr 20087:00 amRNSNotifiable Interest
18th Apr 20085:00 pmRNSNotifiable Interest
18th Apr 20083:36 pmRNSDirector/PDMR Shareholding
31st Mar 20089:56 amRNSTotal Voting Rights
27th Mar 20087:01 amRNSDirector/PDMR Shareholding
26th Mar 20082:24 pmRNSAppointment of Joint Broker
17th Mar 200810:51 amRNSNotifiable Interest
10th Mar 20087:00 amRNSFunds Under Management
29th Feb 20085:01 pmRNSNotifiable Interest
29th Feb 20085:00 pmRNSNotifiable Interest
29th Feb 20087:01 amRNSBuyback & Directors' Dealing
7th Feb 20089:57 amRNSDirector/PDMR Shareholding
6th Feb 20087:01 amRNSDirector/PDMR Shareholding
29th Jan 20087:00 amRNSInterim Results
18th Jan 200811:47 amRNSNotice of Results Correction
18th Jan 20089:07 amRNSNotice of Results
10th Dec 20077:00 amRNSFunds Under Management
30th Nov 20077:01 amRNSDirector/PDMR Shareholding
29th Oct 200712:44 pmRNSResult of AGM
29th Oct 20077:00 amRNSTrading Update
24th Sep 20073:38 pmRNSDirector/PDMR Shareholding
19th Sep 20074:32 pmRNSDirector/PDMR Shareholding
17th Sep 20077:01 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.